The All India Institute of Medical Sciences (AIIMS) in Delhi will begin screening of children aged 2 to 18 years for Covaxin clinical trials from today. Covaxin is indigenously developed anti-Covid vaccine. It is developed by Hyderabad-based biotechnology company Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).The All India Institute of Medical Sciences (AIIMS) in Delhi will begin screening of children aged 2 to 18 years for Covaxin clinical trials from today. Covaxin is indigenously developed anti-Covid vaccine. It is developed by Hyderabad-based biotechnology company Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). June 07, 2021 at 09:23AM https://ift.tt/3cngoqx
No comments:
Post a Comment